Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Target blood pressure level for the treatment of elderly hypertensive patients: a systematic review and meta-analysis of randomized trials


Although recent systematic reviews (SRs) of randomized clinical trials (RCTs) support the benefit of blood pressure (BP) treatment in the elderly, the optimized target BP level remains controversial. We performed a SR to determine the clinical benefit of antihypertensive treatments with a target systolic BP (SBP) of <140 mmHg in the elderly. We searched for RCTs comparing intensive and less intensive treatments or placebo and active treatments reported until May 2017 and identified 11 RCTs in which the target or on-treatment SBP in the intensive or active treatment was less than 140 mmHg. Among the RCTs, 6 RCTs with primary or subanalysis results for patients aged 70 years or older were finally chosen for the meta-analysis. We found that intensive lowering of BP did not reduce the risk ratio (RR) of composite cardiovascular outcomes (95% CI: 0.67–1.05, p = 0.13). By contrast, intensive lowering of BP achieved RR reductions of 24% for all-cause death (0.63–0.92) and of 39% for cardiovascular death (0.48–0.77). Intensive lowering of BP did not alter the incidence of stroke (0.63–1.23) and serious adverse events (SAEs) (0.93–1.09). In conclusion, intensive antihypertensive regimens targeting SBP < 140 mmHg did not significantly reduce the risk of cardiovascular diseases compared to that of less intensive treatments, but did reduce the risk of death without increasing adverse events in patients aged 70 years or older. These findings support the benefit of intensive treatment targeting SBP to ≤140 mmHg in the elderly.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1
Fig. 2
Fig. 3


  1. 1.

    Miura K, Nagai M, Ohkubo T. Epidemiology of hypertension in Japan: where are we now? Circ J. 2013;77:2226–31.

    Article  Google Scholar 

  2. 2.

    Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887–98.

    CAS  Article  Google Scholar 

  3. 3.

    Wilt TJ, Kansagara D, Qaseem A.Clinical Guidelines Committee of the American College of Physician Hypertension Limbo: balancing benefits, harms, and patient preferences before we lower the bar on blood pressure. Ann Intern Med. 2018;168:369–70.

    Article  Google Scholar 

  4. 4.

    Shimamoto K, Ando K, Fujita T, Hasebe N, Higaki J, Horiuchi M. et al.Japanese Society of Hypertension Committee for Guidelines for the Management of Hypertension The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res. 2014;37:253–390.

    Article  Google Scholar 

  5. 5.

    Williamson JD, Supiano MA, Applegate WB, Berlowitz DR, Campbell RC, Chertow GM, et al. Group SR. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥75 years: A Randomized Clinical Trial. J Am Med Assoc. 2016;315:2673–82.

    CAS  Article  Google Scholar 

  6. 6.

    Qaseem A, Wilt TJ, Rich R, Humphrey LL, Frost J, Forciea MA, Clinical Guidelines Committee of the American College of P, the Commission on Health of the P and Science of the American Academy of Family Physician. Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus lower blood pressure targets: a Clinical Practice Guideline From the American College of Physicians and the American Academy of Family Physicians. Ann Intern Med. 2017;166:430–7.

    Article  Google Scholar 

  7. 7.

    Weiss J, Freeman M, Low A, Fu R, Kerfoot A, Paynter R, et al. Benefits and harms of intensive blood pressure treatment in adults aged 60 years or older: a systematic review and meta-analysis. Ann Intern Med. 2018;166:419–29.

    Article  Google Scholar 

  8. 8.

    Amery A, Birkenhager W, Brixko P, Bulpitt C, Clement D, Deruyttere M, et al. Mortality and morbidity results from the European Working Party on high blood pressure in the elderly trial. Lancet. 1985;1:1349–54.

    CAS  Article  Google Scholar 

  9. 9.

    Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. J Am Med Assoc. 1991;265:3255–64.

  10. 10.

    Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet . 1997;350:757–64.

    CAS  Article  Google Scholar 

  11. 11.

    Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet. 1998;351:1755–62.

    CAS  Article  Google Scholar 

  12. 12.

    Group PC. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033–41.

    Article  Google Scholar 

  13. 13.

    Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens. 2003;21:875–86.

    CAS  Article  Google Scholar 

  14. 14.

    Liu L, Zhang Y, Liu G, Li W, Zhang X, Zanchetti A, Group FS. The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients. J Hypertens. 2005;23:2157–72.

    CAS  Article  Google Scholar 

  15. 15.

    Patel A, Group AC, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007;370:829–40.

    CAS  Article  Google Scholar 

  16. 16.

    Ninomiya T, Zoungas S, Neal B, Woodward M, Patel A, Perkovic V, et al. Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial. J Hypertens. 2010;28:1141–9. Group AC

    CAS  PubMed  Google Scholar 

  17. 17.

    Group JS. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res. 2008;31:2115–27.

    Article  Google Scholar 

  18. 18.

    Verdecchia P, Staessen JA, Angeli F, de Simone G, Achilli A, Ganau A, et al. Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial. Lancet. 2009;374:525–33.

    Article  Google Scholar 

  19. 19.

    Group AS, Cushman WC, Evans GW, Byington RP, Goff DC Jr., Grimm RH Jr., Cutler JA, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575–85.

    Article  Google Scholar 

  20. 20.

    Ogihara T, Saruta T, Rakugi H, Matsuoka H, Shimamoto K, Shimada K, et al. Target blood pressure for treatment of isolated systolic hypertension in the elderly: valsartan in elderly isolated systolic hypertension study. Hypertension. 2010;56:196–202.

    CAS  Article  Google Scholar 

  21. 21.

    Group SPSS, Benavente, Coffey OR, Conwit CS, Hart R, McClure RG, Pearce LA, et al. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randomised trial. Lancet. 2013;382:507–15.

    Article  Google Scholar 

  22. 22.

    White CL, Szychowski JM, Pergola PE, Field TS, Talbert R, Lau H. et al.and Secondary Prevention of Small Subcortical Strokes Study I Can blood pressure be lowered safely in older adults with lacunar stroke? The Secondary Prevention of Small Subcortical Strokes study experience. J Am Geriatr Soc. 2015;63:722–9.

    Article  Google Scholar 

  23. 23.

    Group SR, Wright JT, Jr., Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103–16.

  24. 24.

    Wei Y, Jin Z, Shen G, Zhao X, Yang W, Zhong Y, et al. Effects of intensive antihypertensive treatment on Chinese hypertensive patients older than 70 years. J Clin Hypertens. 2013;15:420–7.

    CAS  Article  Google Scholar 

  25. 25.

    Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. Br Med J. 2011;343:d5928.

    Article  Google Scholar 

  26. 26.

    Bavishi C, Bangalore S, Messerli FH. Outcomes of intensive blood pressure lowering in older hypertensive patients. J Am Coll Cardiol. 2017;69:486–93.

    Article  Google Scholar 

  27. 27.

    Hong D, Su H, Li J, Xu J, Peng Q, Yang Q, et al. The effect of physician presence on blood pressure. Blood Press Monit. 2012;17:145–8.

    Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Koichi Yamamoto.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Takami, Y., Yamamoto, K., Arima, H. et al. Target blood pressure level for the treatment of elderly hypertensive patients: a systematic review and meta-analysis of randomized trials. Hypertens Res 42, 660–668 (2019).

Download citation


  • Hypertension
  • The elderly
  • Systematic review
  • Meta-analysis
  • Randomized clinical trial

Further reading

  • Clinical studies on pharmacological treatment of hypertension in Japan

    • Kazuomi Kario
    • , Satoshi Hoshide
    • , Koichi Yamamoto
    • , Ayako Okura
    •  & Hiromi Rakugi

    Journal of Human Hypertension (2021)

  • The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)

    • Satoshi Umemura
    • , Hisatomi Arima
    • , Shuji Arima
    • , Kei Asayama
    • , Yasuaki Dohi
    • , Yoshitaka Hirooka
    • , Takeshi Horio
    • , Satoshi Hoshide
    • , Shunya Ikeda
    • , Toshihiko Ishimitsu
    • , Masaaki Ito
    • , Sadayoshi Ito
    • , Yoshio Iwashima
    • , Hisashi Kai
    • , Kei Kamide
    • , Yoshihiko Kanno
    • , Naoki Kashihara
    • , Yuhei Kawano
    • , Toru Kikuchi
    • , Kazuo Kitamura
    • , Takanari Kitazono
    • , Katsuhiko Kohara
    • , Masataka Kudo
    • , Hiroo Kumagai
    • , Kiyoshi Matsumura
    • , Hideo Matsuura
    • , Katsuyuki Miura
    • , Masashi Mukoyama
    • , Satoko Nakamura
    • , Takayoshi Ohkubo
    • , Yusuke Ohya
    • , Takafumi Okura
    • , Hiromi Rakugi
    • , Shigeyuki Saitoh
    • , Hirotaka Shibata
    • , Tatsuo Shimosawa
    • , Hiromichi Suzuki
    • , Shori Takahashi
    • , Kouichi Tamura
    • , Hirofumi Tomiyama
    • , Takuya Tsuchihashi
    • , Shinichiro Ueda
    • , Yoshinari Uehara
    • , Hidenori Urata
    •  & Nobuhito Hirawa

    Hypertension Research (2019)


Quick links